Clinical Trials Sponsored by Ghulam Nabi

Total 234 results

Ghulam Nabi

Completed

Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.

Reproductive Physiological Phenomena

Pakistan
Nabi Biopharmaceuticals

Completed

Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

Staphylococcal Infections
Nabi Biopharmaceuticals

Completed

Antibody and Safety Study of 6 Doses of NicVAX in Smokers

Smoking

United States
Nabi Biopharmaceuticals

Completed

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Kidney Failure | Hyperphosphatemia

United States
Nabi Biopharmaceuticals

Completed

StaphVAX Immunogenicity in Orthopedic Implant Patients

Staphylococcal Infections | Joint Prosthesis

United States
Nabi Biopharmaceuticals

Completed

Evaluation of Manufacturing Lot of StaphVAX

Staphylococcal Infections | Chronic Kidney Failure

United States
Nabi Biopharmaceuticals

Completed

Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever

Staphylococcal Infections
Nabi Biopharmaceuticals

Completed

StaphVAX in Cardiovascular Surgery Patients

Cardiovascular Diseases | Staphylococcal Infections | Cardiovascular Surgical Procedures

United States
Nabi Biopharmaceuticals

Completed

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

Kidney Failure, Chronic | Staphylococcal Infections
Nabi Biopharmaceuticals

Completed

A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Smoking Cessation | Nicotine Dependence

United States
Nabi Biopharmaceuticals

Completed

A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers

Smoking

United States
Nabi Biopharmaceuticals

Completed

A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

Smoking Cessation

United States
Nabi Biopharmaceuticals

Completed

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Arteriosclerosis | Hyperparathyroidism, Secondary | Calcinosis

United States
Nabi Biopharmaceuticals

Terminated

Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease (SHIELD-2)

Staphylococcal Infections | Chronic Kidney Failure

United States
Nabi Biopharmaceuticals
GlaxoSmithKline

Completed

Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Smoking Cessation

United States
Nabi Biopharmaceuticals
Vanderbilt University

Completed

Evaluation of Consistency of StaphVAX Manufacturing Lots

Staphylococcal Infections

United States
Nabi Biopharmaceuticals
Public Health England

Completed

StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery

Staphylococcal Infections

United Kingdom
Fresenius Kabi Japan

Completed

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage

Japan
Fresenius Kabi Japan

Completed

Trial of 6% HES130/0.4

Hemorrhage | Hypovolemia

Japan
Fresenius Kabi

Not yet recruiting

bIosimilar of aDalimumab, an European evAluation (IDEA)

Rheumatoid Arthritis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis
Fresenius Kabi

Completed

Chronic Kidney Disease Observational Database - Taiwan (CKDOD)

Chronic Kidney Insufficiency

Taiwan
Fresenius Kabi

Terminated

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days

United States
Fresenius Kabi

Terminated

Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness

Critical Illness

France, Germany, Poland
Fresenius Kabi

Completed

Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)

Chronic Kidney Disease

Russian Federation
Fresenius Kabi

Completed

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease | Chronic Heart Failure | Cachexia

Germany, Poland
Fresenius Kabi

Completed

Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake

Malnutrition

Germany
Fresenius Kabi

Completed

Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free Intake

Malnutrition

Germany
Fresenius Kabi

Completed

Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section (CAESAR)

Hypotension

France
Fresenius Kabi

Completed

Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

Parenteral Nutrition

Australia, Denmark, France, Israel, Netherlands, Poland, United Kingdom
Fresenius Kabi

Completed

Gastric Emptying Study After Administration of a High Caloric Sip Feed

Enteral Nutrition

Germany
Gabi SmartCare

Completed

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study) (BRIDGE)

Cardiovascular Diseases | Respiratory Disease | Cardiac Disease | Congenital Cardiac Defect | Premature Infant Disease | Chronic Respiratory Disease | Chronic Cardiopulmonary Disease

United States, Belgium
Fresenius Kabi

Completed

A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response (OPALE)

Rheumatoid Arthritis | Psoriasis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis

France
Fresenius Kabi

Withdrawn

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Malnutrition | Pediatric ALL | Neurocognitive Deficit | Parenteral Nutrition Associated Liver Disease | Essential Fatty Acid Deficiency
Fresenius Kabi

Terminated

Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy

Cancer-related Malnutrition

France
Fresenius Kabi

Completed

Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet

Chronic Kidney Disease

Hungary
Fresenius Kabi

Completed

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Blood Glucose

Germany
Fresenius Kabi

Completed

Screening Day Latin America

Malnutrition | Nutritional Status | Caloric Deficit

Colombia, Brazil, Mexico, Ecuador, Peru, Chile, Argentina, Panama
Fresenius Kabi

Terminated

Fluid Resuscitation in Patients Suffering From Burns Injury

Burns

United Kingdom
Fresenius Kabi

Completed

Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients

Diabetes

Germany
Fresenius Kabi

Completed

Voluven® in Paediatric Patients

Cardiac Surgery | Cardiopulmonary Bypass

Austria, Belgium
Fresenius Kabi

Terminated

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Cancer | Cachexia

Italy, Poland
Fresenius Kabi

Completed

The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients

Enteral Nutrition

Germany
Fresenius Kabi

Terminated

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Intraoperative Complications

China
Fresenius Kabi

Completed

Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery

Enteral Nutrition (Food for Special Medical Purposes)

Italy
Fresenius Kabi

Completed

Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery

Postoperative Complications

China
Fresenius Kabi

Not yet recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Malnutrition | Pediatric ALL | Essential Fatty Acid Deficiency | Parenteral Nutrition Associated Liver Disease (PNALD)
Fresenius Kabi

Not yet recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Malnutrition | Malnutrition, Child

United States
Fresenius Kabi

Completed

Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care

Critical Illness | Nutrition Therapy

Russian Federation
Fresenius Kabi

Terminated

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

Malnutrition, Child

United States
Gabi SmartCare

Completed

Assessment of the Accuracy of the Non-invasive Wireless Armband Gabi Baby Band for Continuous Vital Parameters Monitoring in Infants and Young Children (WAGSC1)

Sleep-Disordered Breathing | Blood Oxygen Desaturations

Belgium

3

Subscribe